ProofPilot Teams Up with Inspire to Boost Patient Participation in Clinical Trials
ProofPilot's platform is purpose-built to optimize recruitment and engagement of patients. By joining ProofPilot's Patient Recruitment Network, Inspire will help activate patients and caregivers from its diverse, global community, empowering them to find the right trials.
The partnership will help to bolster Inspire's impact by:
Expanding opportunities to connect patients in their community with life-advancing clinical trials
Providing a world class, end to end digital experience to optimize participation
'The Inspire community is filled with individuals eager to participate in the advancement and transformation of clinical research,' said Brett Kleger, CEO of Inspire. 'By partnering with a tech company like ProofPilot, we can seamlessly connect patients to meaningful clinical trial opportunities, allowing us to focus on what we do best – holistic, year-round engagement of our community.'
'At ProofPilot, we're committed to transforming the clinical trial experience for both sponsors and patients,' said Chris Venezia, CEO of ProofPilot. 'Our partnership with Inspire allows us to leverage their extensive patient community to accelerate recruitment and connect patients with life-changing research opportunities. We're excited to work with Inspire to break down barriers to study participation.'
About Inspire
Founded in 2005, Inspire connects life sciences organizations with the voices that matter most—patients and caregivers. With a community spanning over 10 million unique annual visitors and more than 3,000 disease states, Inspire leverages its engaged patient communities to deliver critical insights that drive advancements in both research and commercial strategy. Inspire's capabilities include accelerating clinical trial recruitment, uncovering real-world evidence, delivering actionable market research, and providing targeted advertising solutions that reach highly engaged health-focused audiences. By bridging the gap between patients and life sciences, Inspire enables smarter decision-making, more impactful treatments, and a deeper understanding of the communities it serves. Learn more at https://inspireresearch.com.
https://www.proofpilot.com and connect with us on LinkedIn.
Media Contact
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
21-07-2025
- Business Upturn
Sun Pharma reports positive results from Phase 3 trials for ILUMYA
Sun Pharmaceutical Industries has shared encouraging top-line results from two (Phase 3) clinical trials evaluating its biologic drug tildrakizumab 100 mg, marketed as ILUMYA®, for the treatment of active psoriatic arthritis (PsA). The studies, named INSPIRE-1 and INSPIRE-2, tested ILUMYA over a 24-week period. Patients who received ILUMYA showed significant improvements in symptoms of psoriatic arthritis compared to those who received a placebo. Both trials successfully met their primary goal—a higher proportion of patients treated with ILUMYA achieved ACR20 responses, a standard measure used to assess improvement in joint disease, by Week 24. The results were statistically significant. On the safety front, the drug performed as expected. There were no new safety concerns, and the data remained in line with ILUMYA's existing safety record. The drug is already approved to treat moderate-to-severe plaque psoriasis, and these latest findings suggest it may have potential in addressing PsA as well. However, it's important to note that ILUMYA is not yet approved for psoriatic arthritis, and its use for this indication has not been reviewed or authorized by health regulators. Marek Honczarenko, MD, PhD, Senior Vice President and Head of Global Specialty Development at Sun Pharma, stated, 'We are excited to share that both the INSPIRE-1 and INSPIRE-2 clinical trials have successfully met their primary endpoints. These top-line results reinforce the therapeutic potential of ILUMYA as a treatment option for patients with active psoriatic arthritis. We extend our sincere gratitude to the patients, healthcare professionals and administrators whose contributions made the studies possible. We look forward to sharing the complete clinical data in the near future.' Sun Pharma plans to present the full results from these studies at upcoming medical conferences and publish them in peer-reviewed journals. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Miami Herald
15-07-2025
- Miami Herald
Inspire Veterinary Partners Launches Company-Wide Incentive Program
Recent quality of work-life survey demonstrates clinic leader and employee satisfaction, underscoring value of Inspire's approach as new incentive program rolls out VIRGINIA BEACH, VA / ACCESS Newswire / July 15, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced the launch of its company-wide incentive and recognition program, providing vital new engagement tools to provide new avenues to wealth for all employees across their clinic network. The annual incentive program, aligned with the Company's revenue and earnings targets, will monetarily reward clinic and company leaders across the organization for target achievements and launches concurrent to results of the Company's recent quality of work-life survey showing positive leader job satisfaction. "The first half of this year has been outstanding for Inspire Veterinary Partners with new doctors and practice managers hired, our investment in development for all team members, and the launch of our novel incentive program designed to reward performance achievement at Inspire," shared Lynley Kees, Chief People Officer. "We are particularly proud that our newest doctors are sharing the ways that joining Inspire has positively impacted their lives." With a new recognition system and implementation of the new incentive plan, Inspire is committed to investing in its people, further strengthening what it believes is among the most comprehensive total compensation packages in its industry. The quality of work-life survey, conducted with doctors across the country, and facilitated by recruiting and human resources leadership found positive leader job satisfaction, as well as positive feedback on the plan for upcoming incentives. "Transitioning from the ER to the Inspire-owned clinic environment has been life-changing for me," said Dr. Christopher Korte, Associate Doctor, Pets & Friends Animal Hospital, Pueblo, Colorado, "My stress levels have significantly decreased, and my overall quality of life has improved beyond measure. The warmth and camaraderie here have made all the difference, and I feel blessed to be part of such a wonderful community." "I am very happy at Pony Express Animal Hospital, an Inspire-owned clinic in Ohio, and so glad I made the move," shared Dr. Lauren Hudson, Associate Doctor, The Pony Express Animal Hospital, Xenia, Ohio. "My schedule and caseload are perfect, and my quality of life has improved dramatically! Being able to see my child and husband and not be on call 24/7 has helped me both physically and mentally. I can complete my notes and have adequate time to get everything done that I need to as a doctor here." The Company plans more additions to its reward and compensation package within the year. About Inspire Veterinary Partners, Inc. Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care. For more information, please visit: or connect with us on Facebook, LinkedIn, or X. Forward-Looking Statements This press release contains forward-looking statements regarding expectations about additions to employee incentive programs and future acquisitions. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to obtaining additional capital and sourcing and successfully completing future acquisitions, or factors that result in changes to the Company's anticipated results of operations related to the Company's business or acquisitions, such as changes in consumer preferences, the inability to successfully integrate acquisitions, competition and general economic conditions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law. Contact General InquiresMorgan WoodMwood@ MediaMatthew Cossel, CORE PRpr@ SOURCE: INSPIRE VETERINARY PARTNERS, INC.
USA Today
15-07-2025
- USA Today
Inspire Veterinary Partners Launches Company-Wide Incentive Program
Recent quality of work-life survey demonstrates clinic leader and employee satisfaction, underscoring value of Inspire's approach as new incentive program rolls out Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ('Inspire' or the 'Company'), an owner and provider of pet health care services throughout the U.S., today announced the launch of its company-wide incentive and recognition program, providing vital new engagement tools to provide new avenues to wealth for all employees across their clinic network. The annual incentive program, aligned with the Company's revenue and earnings targets, will monetarily reward clinic and company leaders across the organization for target achievements and launches concurrent to results of the Company's recent quality of work-life survey showing positive leader job satisfaction. 'The first half of this year has been outstanding for Inspire Veterinary Partners with new doctors and practice managers hired, our investment in development for all team members, and the launch of our novel incentive program designed to reward performance achievement at Inspire,' shared Lynley Kees, Chief People Officer. 'We are particularly proud that our newest doctors are sharing the ways that joining Inspire has positively impacted their lives.' With a new recognition system and implementation of the new incentive plan, Inspire is committed to investing in its people, further strengthening what it believes is among the most comprehensive total compensation packages in its industry. The quality of work-life survey, conducted with doctors across the country, and facilitated by recruiting and human resources leadership found positive leader job satisfaction, as well as positive feedback on the plan for upcoming incentives. 'Transitioning from the ER to the Inspire-owned clinic environment has been life-changing for me,' said Dr. Christopher Korte, Associate Doctor, Pets & Friends Animal Hospital, Pueblo, Colorado, 'My stress levels have significantly decreased, and my overall quality of life has improved beyond measure. The warmth and camaraderie here have made all the difference, and I feel blessed to be part of such a wonderful community.' 'I am very happy at Pony Express Animal Hospital, an Inspire-owned clinic in Ohio, and so glad I made the move,' shared Dr. Lauren Hudson, Associate Doctor, The Pony Express Animal Hospital, Xenia, Ohio. 'My schedule and caseload are perfect, and my quality of life has improved dramatically! Being able to see my child and husband and not be on call 24/7 has helped me both physically and mentally. I can complete my notes and have adequate time to get everything done that I need to as a doctor here.' The Company plans more additions to its reward and compensation package within the year. About Inspire Veterinary Partners, Inc. Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care. For more information, please visit: or connect with us on Facebook, LinkedIn, or X. Forward-Looking Statements This press release contains forward-looking statements regarding expectations about additions to employee incentive programs and future acquisitions. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to obtaining additional capital and sourcing and successfully completing future acquisitions, or factors that result in changes to the Company's anticipated results of operations related to the Company's business or acquisitions, such as changes in consumer preferences, the inability to successfully integrate acquisitions, competition and general economic conditions. These and other risks and uncertainties are described more fully in the section captioned 'Risk Factors' in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law. Contact General Inquires Morgan Wood Mwood@ Media Matthew Cossel, CORE PR pr@ SOURCE: INSPIRE VETERINARY PARTNERS, INC. View the original press release on ACCESS Newswire
